Channing Capital Management, LLC Medpace Holdings, Inc. Transaction History

Channing Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $15.6 Million - $22.6 Million	-54,664 Reduced 33.02%	110,897 $44.8 Million
Q4 2023 Feb 06, 2024	BUY	$227.52 - $312.68 $11,831 - $16,259	52 Added 0.03%	165,561 $50.7 Million
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $16.5 Million - $19.8 Million	-70,457 Reduced 29.86%	165,509 $40.1 Million
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $63,293 - $81,177	338 Added 0.14%	235,966 $56.7 Million
Q1 2023 May 09, 2023	SELL	$174.31 - $239.52 $1.93 Million - $2.66 Million	-11,100 Reduced 4.5%	235,628 $44.3 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $2.34 Million - $3.46 Million	15,268 Added 6.6%	246,728 $52.4 Million
Q3 2022 Nov 08, 2022	BUY	$145.13 - $182.49 $10.5 Million - $13.2 Million	72,149 Added 45.29%	231,460 $36.4 Million
Q2 2022 Aug 11, 2022	BUY	$130.2 - $168.03 $20.7 Million - $26.8 Million	159,311 New	159,311 $23.8 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Channing Capital Management, LLC with notifications on news.